References
- Ljungberg B, Nilsson–Ehle I. Pharmacokinetics of antimicrobial agents in the elderly. Rev Infect Dis 1987; 9: 250–264
- Harding S M (1982) Clinical pharmacology of ceftazidime. Current chemotherapy and immunotherapy. Proceedings of the 12th International Congress of Chemotherapy, FlorenceItaly, July, 1981, F Periti, G G Grassi. American Society for Microbiology, Washington, DC, 495–498
- Ryan D M, Cars O. A problem in the interpretation of betalactam antibiotic levels in tissues. J Antimicrob Chemother 1983; 12: 281–284
- Ljungberg B, Nilsson–Ehle I. Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males. Eur J Clin Pharmacol 1988; 34: 179–186
- Broechner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271–274
- Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest 1981; 41: 611–616
- Ayrton J. Assay of ceftazidime in biological fluids using high-pressure liquid chromatography. J Antimicrob Chemother 1981; 8: 227–231, Suppl B
- Gibaldi M. Biopharmaceutics and clinical pharmacokinetics, 3rd ed. Lea & Febiger, Philadelphia 1984; 17–28
- Davies D F, Shock N W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496–507
- Ljungberg B, Nilsson–Ehle I. Influence of age on the pharmacokinetics of ceftazidime in acutely ill, adult patients. Eur J Clin Pharmacol 1988; 34: 173–178
- LeBel M, Barbeau G, Vallée F, Bergeron M G. Pharmacokinetics of ceftazidime iiv elderly volunteers. Antimicrob Agents Chemother 1985; 28: 713–715
- Naber K G, Kees F, Grobecker H. Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections. J Antimicrob Chemother 1983; 12: 41–45, Suppl A
- Bruce Å, Andersson M, Arvidsson B, Isaksson B. Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age. Scand J Clin Lab Invest 1980; 40: 461–473
- Ganzinger U, Haslberger A. Pharmacokinetics of cephalosporins in normal and septicemic rabbits. Antimicrob Agents Chemother 1985; 28: 473–477
- Ganzinger U, Haslberger A, Sciel H, Omilian-Rosso R, Schütze E. Influence of endotoxin on the distribution of cephalosporins in rabbits. J Antimicrob Chemother 1986; 17: 785–793
- Perfect J R, Durack D T. Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis. J Antimicrob Chemother 1981; 8: 49–58
- Pennington J E, Dale D C, Reynolds H Y, MacLowry J D. Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever. J Infect Dis 1975; 132: 270–275
- Hassan E, Ober J D. Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients. Antimicrob Agents Chemother 1987; 31: 1855–1858
- Mitchell M D, Wilson J, Dodek P, Russel J. Volume of distribution in patients with Gram negative sepsis in the ICU. Anesthesiology 1987; 67: A126
- Niemiec P W, Allo M D, Miller C F. Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care. Arch Surg 1987; 122: 207–212
- Summer W R, Michael J R, Lipsky J J. Initial aminoglycoside levels in the critically ill. Crit Care Med 1983; 11: 948–950
- Janicke D M, Cafarell R F, Parker S W, Apicella M A, Jusko W J. Pharmacokinetics of aztreonam in patients with Gram-negative infections. Antimicrob Agents Chemother 1985; 27: 16–20
- Ganzinger U, Kleinberger G, Lenz K, Schatz F, Laggner A, Grimm G. Pharmacokinetics of ceftazidime and netilmicin in patients with sepsis. Int J Clin Pharmacol Then Toxicol 1987; 25: 354–362
- Goldblum S E, Reed W P. Effect of intravascular pneumococcal challenge on vascular permeability in rabbits. J Infect Dis 1983; 148: 179
- Bradley S E. Variations in hepatic blood flow in man during health and disease. N Engl J Med 1949; 240: 456–461
- Garaud J-J, Regnier B, Inglebert F, Faurisson F, Bauchet J, Vachon F. Vancomycin pharmacokinetics in critically ill patients. J Antimicrob Chemother 1984; 14: 53–57, Suppl D
- Lüthy R, Blaser J, Bonetti A, Simmen H, Wise R, Siegenthaler W. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother 1981; 20: 567–575
- Sommers D K, Walters L, Van Wyk M, Harding S M, Paton A M, Ayrton J. Pharmacokinetics of ceftazidime in male and female volunteers. Antimicrob Agents Chemother 1983; 23: 892–896